MYMD Insider Trading

9.64% of MyMD Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

MyMD Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/1/2024	Mirae Asset Global Investments Co. Ltd.	875,933	$2.09M	0.0%	-71.8%	40.552%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	3,108,473	$0.80M	0.0%	+230.5%	6.107%
11/13/2023	Cambria Investment Management L.P.	171,570	$0.10M	0.0%	+184.8%	0.382%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	940,602	$0.56M	0.0%	-20.5%	2.093%
10/17/2023	Atlas Brown Inc.	43,500	$26K	0.0%	N/A	0.097%
10/11/2023	Praetorian Wealth Management Inc.	200,000	$0.12M	0.0%	+700.0%	0.445%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	1,183,616	$1.78M	0.0%	+0.9%	2.902%
5/11/2023	Cambria Investment Management L.P.	61,956	$0.11M	0.0%	-10.0%	0.157%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	1,173,610	$2.02M	0.0%	+55.1%	2.973%
4/25/2023	Parallel Advisors LLC	25,125	$43K	0.0%	N/A	0.064%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	756,485	$0.87M	0.0%	+18.5%	1.917%
1/30/2023	International Assets Investment Management LLC	67,000	$77K	0.0%	N/A	0.170%
1/20/2023	Fidelis Capital Partners LLC	38,590	$51K	0.1%	N/A	0.098%
1/11/2023	Praetorian Wealth Management Inc.	25,000	$29K	0.0%	+66.7%	0.063%
11/10/2022	ExodusPoint Capital Management LP	34,456	$90K	0.0%	N/A	0.087%
11/8/2022	Cambria Investment Management L.P.	65,398	$0.17M	0.0%	N/A	0.166%
11/7/2022	Bridgecreek Investment Management LLC	65,000	$0.17M	0.0%	N/A	0.165%
10/25/2022	Raymond James Financial Services Advisors Inc.	24,801	$65K	0.0%	N/A	0.065%
10/21/2022	Aaron Wealth Advisors LLC	50,000	$0.13M	0.0%	N/A	0.131%
8/12/2022	Ikarian Capital LLC	81,089	$0.18M	0.0%	-38.3%	0.213%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	1,073,765	$2.33M	0.0%	+13.8%	2.821%
7/18/2022	Western Wealth Management LLC	27,050	$0.12M	0.0%	-11.9%	0.071%
7/14/2022	Praetorian Wealth Management Inc.	15,000	$32K	0.0%	N/A	0.039%
7/8/2022	Taylor & Morgan Wealth Management LLC	17,086	$37K	0.0%	N/A	0.045%
6/2/2022	Mirae Asset Global Investments Co. Ltd.	943,667	$4.40M	0.0%	+23.5%	2.479%
5/24/2022	M Holdings Securities Inc.	70,909	$0.33M	0.0%	N/A	0.186%
5/17/2022	Shay Capital LLC	321,187	$1.50M	0.2%	-10.2%	0.844%
5/10/2022	Mirae Asset Global Investments Co. Ltd.	151,751	$0.71M	0.0%	-80.1%	0.399%
5/10/2022	Western Wealth Management LLC	30,713	$0.14M	0.0%	N/A	0.081%
2/15/2022	Shay Capital LLC	357,790	$2.17M	0.4%	+81.4%	0.951%
2/15/2022	683 Capital Management LLC	59,410	$0.36M	0.0%	N/A	0.158%
2/10/2022	Qube Research & Technologies Ltd	21,674	$0.13M	0.0%	N/A	0.058%
2/8/2022	Mirae Asset Global Investments Co. Ltd.	764,245	$4.63M	0.0%	-32.5%	2.030%
2/7/2022	Corundum Group Inc.	19,600	$0.12M	0.1%	+74.4%	0.052%
2/1/2022	Qube Research & Technologies Ltd	21,674	$0.13M	0.0%	N/A	0.058%
1/21/2022	Taylor & Morgan Wealth Management LLC	17,836	$0.11M	0.1%	N/A	0.047%
11/15/2021	Invesco Ltd.	235,194	$1.69M	0.0%	N/A	0.629%
11/12/2021	Geode Capital Management LLC	285,671	$2.06M	0.0%	+5.4%	0.764%
11/12/2021	NorthRock Partners LLC	1,354,004	$9.75M	0.8%	-6.5%	3.623%
11/9/2021	BlackRock Inc.	146,633	$1.06M	0.0%	+42.3%	0.392%
8/19/2021	M Holdings Securities Inc.	70,909	$0.45M	0.0%	N/A	0.192%
8/16/2021	Morgan Stanley	714,251	$4.50M	0.0%	N/A	1.937%
8/16/2021	Charles Schwab Investment Management Inc.	13,965	$88K	0.0%	N/A	0.038%
8/16/2021	State Street Corp	26,063	$0.16M	0.0%	N/A	0.071%
8/16/2021	Shay Capital LLC	562,200	$3.54M	0.4%	N/A	1.524%
8/13/2021	Northern Trust Corp	23,049	$0.15M	0.0%	N/A	0.062%
8/13/2021	Geode Capital Management LLC	271,083	$1.71M	0.0%	N/A	0.735%
8/13/2021	Vanguard Group Inc.	1,525,321	$9.61M	0.0%	N/A	4.136%
8/12/2021	NorthRock Partners LLC	1,448,180	$9.12M	0.8%	N/A	3.927%

Data available starting January 2016

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic analog of cannabidiol for treating epilepsy, pain, and anxiety/depression. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Today's Range

Now: $1.36

$1.35

$1.50

50 Day Range

MA: $1.40

$1.10

$1.82

52 Week Range

Now: $1.36

$1.75

$63.90

Volume

128,784 shs

Average Volume

134,123 shs

Market Capitalization

$3.22 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.15

Who are the company insiders with the largest holdings of MyMD Pharmaceuticals?: MyMD Pharmaceuticals' top insider investors include:
Paul Rivard (Insider)
Learn More about top insider investors at MyMD Pharmaceuticals.